Forum Markets, Inc. (FRMM)
6.00
+0.52
(+9.49%)
USD |
NASDAQ |
Aug 24, 16:00
6.00
0.00 (0.00%)
After-Hours: 20:00
Forum Markets EPS Diluted (Quarterly) : -0.7511 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7511 |
| March 31, 2026 | -3.580 |
| December 31, 2025 | -12.05 |
| September 30, 2025 | -16.80 |
| June 30, 2025 | -3.026 |
| March 31, 2025 | -6.693 |
| December 31, 2024 | -13.44 |
| September 30, 2024 | -8.532 |
| June 30, 2024 | 0.0128 |
| March 31, 2024 | -1.676 |
| December 31, 2023 | -2.295 |
| September 30, 2023 | -24.53 |
| June 30, 2023 | -13.37 |
| March 31, 2023 | -24.15 |
| December 31, 2022 | -206.92 |
| September 30, 2022 | -208.39 |
| June 30, 2022 | 32.74 |
| March 31, 2022 | 17.44 |
| December 31, 2021 | 11.57 |
| Date | Value |
|---|---|
| September 30, 2021 | 88.03 |
| June 30, 2021 | -283.37 |
| March 31, 2021 | -220.21 |
| September 30, 2020 | -187.04 |
| June 30, 2020 | 58.56 |
| March 31, 2020 | -537.32 |
| December 31, 2019 | -24.74 |
| September 30, 2019 | -1.942 |
| June 30, 2019 | -0.9728 |
| March 31, 2019 | 6.570 |
| December 31, 2018 | 31.18 |
| September 30, 2018 | 8.162 |
| June 30, 2018 | 5.392 |
| March 31, 2018 | 4.970 |
| December 31, 2017 | 5.753 |
| September 30, 2017 | 2.200 |
| June 30, 2017 | 3.80 |
| March 31, 2017 | -9.158 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | -0.3539 |
| Corcept Therapeutics, Inc. | 0.356 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.42M |
| Revenue (Quarterly) | 1.365M |
| Total Expenses (Quarterly) | 13.79M |
| Enterprise Value | 94.24M |
| Gross Profit Margin (Quarterly) | -39.41% |
| Profit Margin (Quarterly) | -910.0% |
| Earnings Yield | -553.1% |
| Normalized Earnings Yield | -390.34 |